Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Features

831 Features
Swine Flu Update: 21/08/2009

21 Aug 09

Weekly Swine Flu Update for the Week Ending August 16th.
Max Golby

Weekly Swine Flu Update

30 Jul 09

Weekly Swine Flu Update for the Week Ending July 26.
Max Golby

Career Focus: Medical Communications

29 Jul 09

The field of Medical Communications offers a whole host of opportunities for new science graduates - both in medical publishing and pharma.
Max Golby

NHS finances: All Bets Are Off

28 Jul 09

Ahead of the NHS Confederation Conference last month, David Nicholson, Chief Executive of NHS pulled no punches with his assessment of NHS finances.
Miriam George

ABPI Medical Representatives Exam bookings

27 Jul 09

ABPI have developed an on-line exam bookings website to facilitate the process of booking the ABPI Medical Representatives Exam.
ABPI

The Wireless GP

22 Jul 09

Generational stereotypes are never easy to swallow, but when it comes to doctors and an investment in social media, the new generations of medical professionals are increasingly going online for both professional collaboration and patient support.
Max Golby

Drug repositioning strategies: a different approach to innovation

15 Jul 09

With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more bang for its R&D buck by generating some return out of failed drug candidates and extra return out of others. Drug re-positioning has become a key strategy for pharmaceutical groups, and according to Datamonitor, this approach is set to become more frequently employed.
Priyanka Adhikari

World Vaccine Congress Asia: vast regional diversity requires flexibility and targeted portfolios

01 Jul 09

Spanning one third of the globe's circumference and home to more than half of the world's population, the Asia Pacific region is incredibly diverse. This year's World Vaccine Congress Asia highlighted the enormous variation in the vaccine landscape in the region, owing to a myriad of political, cultural, economic and geographic differences.
Priyanka Adhikari

Quick Look: Alternative Therapies

16 Jun 09

Quick Look article from Max Golby about Alternative Therapies
Max Golby

Pharmaceutical Curriculum Vitae, Works of Art or Dissertations?

15 Jun 09

Unless it paints the right picture you’re letting the side down!

In a depressed job market, an employer is likely to receive 50+ CVs per job advertised from 5 or more Preferred Agencies and many more from agencies who ‘piggy back’ in. So now, more than ever, your CV needs to stand out and be tailored to the role and client and submitted by an agency with valid access.
Avril Horn PhD

Serono’s Erbitux set to be first biologic treatment for mCRC in the UK

11 Jun 09

Dr Wolfgang Wein, Executive Vice-President of Merck Serono’s Oncology Business comments on the recent final appraisal determination by NICE paving the way for its leading oncology product Erbitux to benefit UK mCRC patients.
Olwen Glynn Owen - Pharmiweb Field reporter

Quick Look: Swine Flu

03 Jun 09

Quick Look article written by Max Golby, focusing on topic of swine flu.
Max Golby

Impact of the credit crunch: how will the NHS respond to its two year window of opportunity?

20 May 09

Senior Department of Health executives, speaking at a recent NHS Alliance Conference, suggested that the NHS has two years left before it starts to the credit crunch’s bite – maybe less if there is an election in a years’ time. But this should not be cause complacency in the health sector. The message is, invest wisely now so that you are well prepared for the fallow times ahead.
PDC Healthcare

Global Pain Management Set to Drive Transdermal Patches and Gels to $8 Billion in 2012

18 May 09

The growing incidence of diseases and conditions related to aging is creating pockets of opportunity for pain management. These opportunities include the expanding use of prescription NSAIDs as second-line therapies for chronic pain and an increase in off-label prescribing. As populations and indications evolve, so too is the pain management sector.
Applied Data Research

Consumer Marketing Moves in a New Direction for Pharma

14 May 09

In this edition of StrategicEdge, CBR Pharma Insights discusses the current trends and opportunities that exist in marketing to consumers as the age of TiVo, DVRs, and cost constraints point the industry towards creative uses of the internet and other e-technologies.
CBR Pharma Insights

Antiviral sales boosted as UAE prepares for influenza A (H1N1)

11 May 09

The recent outbreak of influenza A (H1N1) infection, previously referred to as swine flu, has thrown the spotlight on governments around the world and their ability to manage a pandemic. In the UAE, customers are currently finding it difficult to source antivirals but, with Dubai seen as a hub for international travel, the government has stockpiles ready for distribution should an outbreak occur.
Datamonitor

Tired of Twittering? 21,000 Pharmaceutical executives opt for business over social.

08 May 09

There has been no shortage of conversation lately about current problems facing the Pharmaceutical industry...
Fred Beadon

Newly Launched Global Health Education Foundation Seeks to Reduce Health Disparities Across the World

08 May 09

At least 1.3 billion people worldwide lack access to the most basic healthcare, with this burden being greatest in countries overwhelmed by poverty. Since the gap between rich and poor is widening, the Global Health Education Foundation (GHEF: www.globalhef.org) has been set up to tackle worsening disparities in healthcare.
Dr John Wei

UK budget heralds price cuts on branded pharmaceuticals

05 May 09

As part of the UK government's drive to save over GBP2 billion in the NHS during 2010-11, GBP550m will be cut from the prices of branded drugs as a result of the revised Pharmaceutical Price Regulation Scheme. With the volume of branded drugs having remained flat over the last four years, total sales of the UK branded pharmaceutical industry are forecast to decline from 2009 onwards.
Editor

Swine flu (H1N1) reminds us our flu vaccine technologies need updating

30 Apr 09

The latest outbreak of influenza virus H1N1 “swine flu” is now widely tipped to cause a global pandemic of unknown severity. Previously, the influenza vaccine community discussed the theoretical limitations of current technologies and capacity. Now they are faced with the reality of these limitations. VacZine Analytics believes H1N1 must change the science of influenza vaccines.
VacZine Analytics Group

Graduates and the Recession

30 Apr 09

Where the pharmaceutical industry is often said to be immune to economic depression, the current economic crisis cannot be considered a direct historical equal to the recessions of the past.
Max Golby

What do the public think of the pharma industry?

28 Apr 09

Public opinion has for long been regarded as essential to the success of a thriving business. In fact, whilst the benefits of popular perception can often appear somewhat intangible on the balance sheet, what is essentially the respect of the customer is the bastion of almost every profession
Max Golby

Pharmaceutical Trends Impacting New Product Development

20 Apr 09

Despite the current economic downturn, pharmaceutical research & development spending continues to play a vital role in the pharmaceutical industry. The industry, as a whole, needs to find new, more innovative ways to compensate for the recent and upcoming patent loses of many blockbusters products...
CBR Pharma Insights

G20 economic stimulus packages offer little direct aid to branded pharmaceutical players

20 Apr 09

Any positive effect on the pharmaceutical industry derived from the G20 summit and European Union summit will be indirect and much of the direct healthcare spending increase will cover the cost of cheaper generics accessed through publically funded programs. Furthermore, emerging markets previously targeted to drive revenue growth face potentially crippling consequences from the downturn.
Pharmiweb editor

Career in Medical Communications: Integrated versus Individual

06 Apr 09

Medical communications provide professional, valuable marketing solutions to pharmaceutical companies, incorporating; writing, design, multimedia, conferences and events and more.
Claire Phillpot

How to Stay Ahead of the Competition in a Challenging Pharmaceutical Job Market

03 Apr 09

We have all heard the doom and gloom regarding the financial markets/ credit crunch/ recession. It’s pretty hard to escape it. The high earning bankers are jobless and the face of our high street is changing with high profile collapses of organisations including Woolworths, the Officers Club, MFI and Barretts.
Chantal Williams- RSA executive search consultant

Quick Look: Central Nervous System

03 Apr 09

It is perhaps fitting, if not entirely coincidental, that the month that we chose to focus on the important areas of the central nervous system and pain, also coincides with Multiple Sclerosis Awareness Month.
Max Golby

Quick Look: Pain

31 Mar 09

For some patients, namely those suffering from terminal illness, pain relief is an issue that talks to them about the right to end their lives in relative comfort and dignity. In such situations, new kinds of research that attack the complications and side effects of high level pain killers – such as opium based pain relievers – are particularly pertinent.
Max Golby

Career in Medical Communications: Integrated versus Individual

16 Mar 09

Adventis Health is one of a number of medical communications agencies that offers an integrated service with advertising, PR, Medical Education and digital media all available in house.
Adventis Health

Advertising